Clinical Trials at Phoenix Children's Hospital
As of July 2026, 61 paid clinical trials are recruiting at Phoenix Children's Hospital, located at 1919 E THOMAS RD, PHOENIX, AZ 85016-7710, phone (602) 933-1000 in Phoenix, Arizona. Active studies at this site cover conditions such as Obesity, Alzheimer Disease and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Phoenix
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
62 clinical trials at Phoenix Children's Hospital
·Clear filters·↓ Download CSVA Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Child and Adolescent Registry for Participants With Narcolepsy
A Long-term Follow-up Study in Patients Who Received BEAM-101
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
Danon Disease Natural History Study
Pediatric Down Syndrome Post-Approval Study
MSC EVs in Dystrophic Epidermolysis Bullosa
Bowel Continence Across the Lifespan in People With Spina Bifida
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
I-DECIDE After Bronchiolitis Hospitalization
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Distal Radius Interventions for Fracture Treatment
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
About research studies in Phoenix
Phoenix has approximately 855 recruiting research studies across a wide range of therapeutic areas. Arizona is home to Mayo Clinic Arizona, Banner - University Medical Center, and TGen (Translational Genomics Research Institute), with active research in oncology and precision medicine.
Common conditions studied in Phoenix
- Obesity (17 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Alzheimer Disease (16 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Heart Failure (16 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Acute Myeloid Leukemia (10 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Amyotrophic Lateral Sclerosis (9 active studies). Recruiting Amyotrophic Lateral Sclerosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Phoenix
- AstraZeneca
- Eli Lilly and Company
- Mayo Clinic
- National Cancer Institute (NCI)
- Arizona State University
Local regulations and guidelines
Clinical trials in Arizona are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Arizona research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Phoenix. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Phoenix
Hipa.ai aggregates every recruiting study in Phoenix from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Phoenix?
There are approximately 855 recruiting clinical trials in Phoenix, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Phoenix pay participants?
Most recruiting trials in Phoenix compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Phoenix?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Phoenix?
The most common conditions under active study in Phoenix include Obesity (17), Alzheimer Disease (16), Heart Failure (16), Acute Myeloid Leukemia (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Phoenix?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Phoenix on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Phoenix?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Phoenix?
Recruiting research sites in Phoenix include Phoenix Children's Hospital, Cancer Center at Saint Joseph's, Mayo Clinic Hospital in Arizona, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Phoenix right now?
The largest active categories in Phoenix are Cancer & tumors (226), Neurology & pain (75), Cardiovascular (57). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Phoenix Children's Hospital?
Phoenix Children's Hospital is located at 1919 E THOMAS RD, PHOENIX, AZ 85016-7710. Use the Google Maps link in the intro above to get directions.
How do I contact Phoenix Children's Hospital?
You can reach Phoenix Children's Hospital by phone at (602) 933-1000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.